ID: ALA107085

Max Phase: Preclinical

Molecular Formula: C13H8Cl2O2

Molecular Weight: 267.11

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1ccc(-c2ccc(Cl)cc2Cl)cc1

Standard InChI:  InChI=1S/C13H8Cl2O2/c14-10-5-6-11(12(15)7-10)8-1-3-9(4-2-8)13(16)17/h1-7H,(H,16,17)

Standard InChI Key:  OZFFPJBMCGKDGO-UHFFFAOYSA-N

Associated Targets(non-human)

Human papillomavirus regulatory protein E2 38 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 267.11Molecular Weight (Monoisotopic): 265.9901AlogP: 4.36#Rotatable Bonds: 2
Polar Surface Area: 37.30Molecular Species: ACIDHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.03CX Basic pKa: CX LogP: 4.49CX LogD: 1.34
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.88Np Likeness Score: -0.74

References

1. Hajduk PJ, Dinges J, Miknis GF, Merlock M, Middleton T, Kempf DJ, Egan DA, Walter KA, Robins TS, Shuker SB, Holzman TF, Fesik SW..  (1997)  NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein.,  40  (20): [PMID:9379433] [10.1021/jm9703404]

Source